Clinical Trials Logo

Clinical Trial Summary

This is an open-label study to compare systemic exposure to triamcinolone acetonide following a dose of extended-release FX006 or immediate-release TAcs (triamcinolone acetonide suspension) in patients with osteoarthritis of the shoulder (glenohumeral joint) or hip


Clinical Trial Description

This is a randomized, open-label, single dose study that will be conducted in male and female patients ≥40 years of age with OA of either the shoulder or the hip. Approximately 24 patients with OA of the shoulder and approximately 24 patients with OA of the hip will be randomized to one of two treatment groups (1:1) and treated with a single IA injection of either: - 32 mg FX006 (approximately 12 patients per joint) or - 40 mg TAcs (approximately 12 patients per joint) Each patient will be screened to confirm the diagnosis of OA of either the shoulder or hip and eligibility based on the other inclusion/exclusion requirements and will be randomized to treatment on Day 1. Each patient will be evaluated for a total of 12 weeks following the IA injection. Following screening, sampling for pharmacokinetics (PK) and safety will be completed at 10 out-patient visits scheduled on Study Days 1 [calendar day of injection], 2, 3, 5, 8, 15, 22, 29, 57, and 85. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03382262
Study type Interventional
Source Pacira Pharmaceuticals, Inc
Contact
Status Completed
Phase Phase 2
Start date December 18, 2017
Completion date October 9, 2018

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05160441 - Comparing Platelet Rich Plasma and Corticosteroid for Military & Civilian Patients With Glenohumeral Osteoarthritis Phase 3
Suspended NCT02204228 - TITAN™ Reverse Shoulder System
Recruiting NCT04468178 - Clinical Results and RSA Migration Analysis of the GLOBAL ICON - Stemless Anatomic Shoulder N/A
Withdrawn NCT03770546 - Amnion-Based Injections in the Shoulder N/A
Active, not recruiting NCT05049993 - Pyrocarbon Clinical Follow-up Study
Terminated NCT04160091 - Study to Evaluate the Efficacy and Safety of FX006 in Patients With Glenohumeral Osteoarthritis or Shoulder Adhesive Capsulitis Phase 2
Completed NCT00479687 - SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder N/A
Recruiting NCT04228419 - TSA vs RSA in Glenohumeral Osteoarthritis N/A
Enrolling by invitation NCT03404778 - Comprehensive Reverse Shoulder Data Collection
Completed NCT02052206 - Reconstruction of Complex Proximal Humeral Fractures. N/A
Completed NCT03887650 - LIBERATE - LIposomal Bupivacaine vERsus Adjuncts in Total shouldErs Phase 4
Active, not recruiting NCT04634773 - Unravelling the Etiology of Shoulder Osteoarthritis N/A
Completed NCT01697865 - Reverse Shoulder Arthroplasty With or Without Concomitant Latissimus and Teres Major Transfer for Shoulder Pseudoparalysis With Teres Minor Dysfunction N/A
Enrolling by invitation NCT03806881 - Long Term Follow-up After Primary or Revision Shoulder Arthroplasty With a Patient- Specific Glenius Implant
Active, not recruiting NCT01587560 - A Comparison Between a Pyrocarbon and a CoCr Shoulder Resurfacing Implant N/A
Completed NCT03385408 - Effectiveness of HILT in Shoulder Osteoarthritis N/A
Active, not recruiting NCT03097406 - Functional Outcome and Complications After Global Unite ® Prostheses
Active, not recruiting NCT03409718 - Database Retrieval for the Comprehensive Shoulder
Withdrawn NCT04134442 - Improving Pain Management After Total Shoulder Replacement Using Bupivacaine Liposome Phase 4
Active, not recruiting NCT03726554 - Post-Market Study of Comprehensive Reverse Augmented Glenoid and Mini Humeral Tray in Total Shoulder Arthroplasty N/A